Discovering Infectious Determinants of Chronic Diseases: Hospitals, Academia & Donors Partner in Research with TLI

Discovering Infectious Determinants of Chronic Diseases: Hospitals, Academia & Donors Partner in Research with TLI

Initiatives underway to advance regenerative medicine program, identify cause of chronic illnesses, such as Lyme disease, Bartonellosis, rheumatoid arthritis, lupus, neuropsychiatric diseases and Crohn’s disease

MCLEAN, Va.-(BUSINESS WIRE)- With an emphasis on the discovery of infectious determinants of chronic diseases, a goal to reduce chronic disease worldwide and the dedication to make significant advances in regenerative medicine, the Thought Leadership & Innovation Foundation (TLI) is partnering with hospital systems and academic institutions and inviting donor support for the continuation of research.

TLI to Assist Mayo Clinic in Development of a Limb Loss and Preservation Registry

TLI to Assist Mayo Clinic in Development of a Limb Loss and Preservation Registry

Mayo Clinic has awarded a subcontract to the Thought Leadership & Innovation Foundation (TLI) to assist with the development and launch of a Limb Loss and Preservation Registry for the National Institute of Child Health and Human Development. This single award indefinite delivery/indefinite quantity (IDIQ) contract has a ceiling of $5 million over a five-year period. For the past three years, TLI has worked with the Mayo Clinic, the American Joint Replacement Registry (AJRR), and the American Orthotic & Prosthetic Association (AOPA) to advance rehabilitation of individuals having undergone limb loss and limb preservation surgeries.